Topical formula strength describes the amount, delivery, and clinical effectiveness of an active ingredient in a product. Store-bought and doctor-prescribed formulas are not automatically “weak” and “strong”: an over-the-counter product can match or exceed a prescription product in concentration, while a prescription may be more potent because of its ingredient, vehicle, absorption, or approved indication. The U.S. Food and Drug Administration (FDA), American Academy of Dermatology (AAD), and National Institutes of Health (NIH) all emphasize that safety and effectiveness depend on the specific active ingredient, dose, formulation, and patient—not merely on where the product was purchased.
Topical Formula Strength and Regulatory Classification
Topical formula strength is the clinically relevant capacity of a product to produce an intended effect when applied to the skin. It includes active-ingredient concentration, chemical form, penetration through the skin, stability, release rate, and the amount applied. A prescription formula is a medication legally restricted to use under the direction of a licensed prescriber, whereas an over-the-counter (OTC) formula may be purchased without an individual prescription when it complies with an FDA monograph or has specific FDA authorization.
This distinction creates several related categories: OTC drugs, prescription drugs, cosmetics, compounded preparations, and medical devices. Cosmetics may improve appearance but generally cannot legally claim to treat or prevent disease. Prescription products may contain an ingredient unavailable OTC, a higher concentration, or a formulation designed for a specific diagnosis. However, “prescription” is a regulatory and clinical category, not a universal measurement of potency.
Concentration Versus Delivered Dose
Concentration is the quantity of active ingredient in a given amount of product, such as 1% hydrocortisone or 0.025% tretinoin. Delivered dose is the amount that reaches the target tissue during actual use. Two creams with the same percentage may produce different results because one uses a more absorbable vehicle, stays on the skin longer, or releases the medicine more efficiently.
The FDA regulates active ingredients and labeling, but consumers often compare percentages as if they were interchangeable across products. They are not. A 0.1% concentration of one active ingredient cannot be ranked as weaker or stronger than a 1% concentration of another. Even within one ingredient, cream, gel, lotion, ointment, foam, and solution forms can differ in absorption and irritation.
Prescription Status Does Not Always Mean Higher Percentage
Prescription status may reflect a medicine’s safety profile, treatment indication, patient-monitoring requirements, or lack of an approved OTC pathway. For example, adapalene 0.1% became available OTC in the United States for acne, while other retinoids and some higher-strength adapalene products remain prescription medicines. Tretinoin, commonly used for acne and photoaging, is generally prescription-only in the United States even though its concentrations are often numerically lower than some OTC retinoid products.
The practical implication is that a lower percentage can still be clinically powerful. Retinoids act through different molecular pathways and have different evidence bases, so comparing percentages alone can mislead consumers.
Over-the-Counter Formula Strength in Common Products
Hydrocortisone and Anti-Inflammatory Products
In the United States, hydrocortisone 0.5% and 1% products are widely available OTC for short-term relief of minor itching and irritation. Stronger topical corticosteroids, and some formulations intended for particular body sites or diagnoses, require a prescription. Prescription corticosteroid strength is commonly classified from very high potency to low potency, and the same percentage may have a different clinical effect depending on the corticosteroid molecule and vehicle.
More potent steroids can rapidly reduce inflammation but also increase the risk of skin thinning, stretch marks, visible small blood vessels, acne-like eruptions, and systemic absorption when used improperly. The AAD recommends using topical corticosteroids according to medical instructions, especially on the face, skin folds, genitals, and in children.
Acne Ingredients
OTC acne formulas commonly contain benzoyl peroxide, salicylic acid, or adapalene. Benzoyl peroxide products are sold in several strengths, often from 2.5% to 10%. Higher concentration does not necessarily produce better acne control: research published in dermatology literature has found that lower-strength benzoyl peroxide can be effective while causing less irritation for some users.
Prescription acne treatments may include tretinoin, tazarotene, trifarotene, azelaic acid, clindamycin combinations, or oral medicines. Their advantage may be a different mechanism, stronger clinical evidence for a specific severity of acne, or combination treatment rather than simply a higher percentage. The American Academy of Dermatology recommends combining appropriate topical agents and allowing several weeks for improvement rather than repeatedly escalating strength.
Cosmetic Serums and Nonprescription Actives
Store-bought cosmetic products may contain retinol, niacinamide, vitamin C, peptides, exfoliating acids, or botanical ingredients. These products can be useful, but cosmetic labeling does not guarantee that a product has undergone the same premarket demonstration of effectiveness required for an FDA-approved prescription drug. Retinol, for example, must be converted in the skin through intermediate steps before becoming retinoic acid, while tretinoin is already retinoic acid.
This difference explains why a prescription retinoid may produce more predictable acne or photoaging effects even when an OTC product advertises a higher numerical percentage. It also explains why irritation, dryness, and sun sensitivity can occur with either category.
Doctor-Prescribed Formula Strength and Clinical Use
Diagnosis-Specific Potency
A prescription formula is selected for a diagnosis, body location, severity, medical history, and treatment goal. A dermatologist may prescribe a medium- or high-potency corticosteroid for a thick plaque of psoriasis but choose a low-potency product for facial dermatitis. The medicine may therefore be “stronger” in clinical effect because it is matched to the condition and site, not because its label displays the highest percentage.
Prescription treatment can also provide access to combinations that are difficult to reproduce with OTC products, such as an antibiotic paired with benzoyl peroxide or a retinoid paired with another anti-inflammatory ingredient. These combinations may improve adherence and reduce the risk of antibiotic resistance when used under supervision.
Vehicle, Absorption, and Compounding
The vehicle is the base carrying the active ingredient. Ointments are generally more occlusive than creams and may increase hydration and penetration. Gels and solutions can feel lighter and may be preferred for oily or hair-bearing areas. Foams can spread easily over large areas. A prescriber may select a vehicle to change tolerability, absorption, cosmetic feel, or contact time.
Compounded prescriptions are prepared for an individual patient when an appropriate commercial product is unavailable or unsuitable. The FDA notes that compounded drugs are not FDA-approved in the same manner as commercially manufactured drugs, meaning the agency does not independently verify the safety, effectiveness, or quality of every compounded preparation before use. Patients should obtain them from appropriately licensed pharmacies and confirm storage and beyond-use instructions.
How Much Stronger Are Prescription Formulas?
There is no single percentage that answers this question. The following comparisons illustrate why:
- Hydrocortisone 1% OTC may be weaker than many prescription corticosteroids, but it can still cause harm with prolonged or inappropriate use.
- Adapalene 0.1% OTC may be effective for acne, while prescription tretinoin at a different concentration is not directly comparable by percentage.
- Benzoyl peroxide 2.5% may control acne with less irritation than a 10% product for some people.
- A prescription product may have the same active-ingredient percentage as an OTC product but use a different vehicle or dosing schedule.
- A cosmetic serum may list a high concentration but have less predictable clinical performance because its active ingredient, stability, penetration, or testing differs.
A useful comparison chart would therefore place active ingredient, concentration, formulation, regulatory category, approved use, evidence, and common adverse effects in separate columns. Ranking products only from “weakest” to “strongest” would omit the factors that most influence real-world results.
Evidence, Not Marketing Language
Terms such as clinical strength, professional strength, maximum strength, medical grade, and prescription strength are not interchangeable scientific measurements. Some are regulated only in limited contexts, while others are marketing language. Consumers should check the active ingredient, exact concentration, directions, expiration date, and warnings rather than relying on packaging claims.
The FDA’s Drug Facts labeling system is designed to make OTC active ingredients, uses, warnings, and directions easier to compare. For prescription medicines, the official prescribing information and the clinician’s instructions provide more relevant information than a product’s promotional description.
Safety, Effectiveness, and Practical Decision-Making
When an OTC Formula May Be Reasonable
An OTC product may be appropriate for a mild, familiar problem with clear labeling, such as occasional minor irritation or uncomplicated mild acne. Users should follow the labeled amount and frequency, introduce one active ingredient at a time, and stop if severe burning, swelling, blistering, or worsening occurs.
When Medical Evaluation Is More Important
Medical evaluation is advisable when symptoms are severe, widespread, recurrent, painful, infected-looking, rapidly changing, or unresponsive to a properly used OTC product. Extra caution is needed for infants and children, pregnancy, breastfeeding, immunosuppression, diabetes, allergies, and use on the eyes, face, genitals, or broken skin.
A prescription is not a guarantee of a better outcome, and an OTC product is not inherently inferior. The best formula is the one with an appropriate active ingredient, evidence-supported strength, suitable vehicle, manageable side effects, and instructions that the patient can follow consistently.
Conclusion: Comparing Formula Strength by Clinical Effect
Topical formula strength is broader than concentration and cannot be inferred solely from the words OTC or prescription. Over-the-counter products can contain effective, evidence-supported actives, while doctor-prescribed formulas may offer different ingredients, combinations, vehicles, or diagnosis-specific potency. Hydrocortisone, acne treatments, retinoids, cosmetic serums, and compounded medicines demonstrate that numerical percentages are meaningful only when the ingredient and formulation are also considered.
Before switching to a stronger product, compare the active ingredient, concentration, dosage form, intended use, warnings, and evidence. Consult a pharmacist or clinician for persistent or high-risk skin problems, and use the FDA’s Drug Facts label and official prescribing information for further reading. This approach reduces preventable side effects while improving the chance that either a store-bought or prescribed formula will work as intended.
Sources: U.S. Food and Drug Administration, Understanding Over-the-Counter Medicines, https://www.fda.gov/drugs/buying-using-medicine-safely/understanding-over-counter-medicines; U.S. Food and Drug Administration, Drug Facts Label, https://www.fda.gov/drugs/drug-information-consumers/drug-facts-label; U.S. Food and Drug Administration, Compounding and the FDA: Questions and Answers, https://www.fda.gov/drugs/human-drug-compounding/compounding-and-fda-questions-and-answers; American Academy of Dermatology Association, Acne: Diagnosis and Treatment, https://www.aad.org/public/diseases/acne/derm-treat; American Academy of Dermatology Association, Topical Corticosteroids, https://www.aad.org/member/clinical-quality/guidelines/psoriasis/topical-corticosteroids; National Institutes of Health, MedlinePlus: Topical Corticosteroids, https://medlineplus.gov/ency/article/000822.htm; U.S. Food and Drug Administration, Differin Gel Adapalene 0.1% Labeling, https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/020380s012lbl.pdf